SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-043233
Filing Date
2021-08-11
Accepted
2021-08-11 08:30:53
Documents
14
Period of Report
2021-08-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20210811.htm   iXBRL 8-K 37428
2 EX-99.1 fgen-ex991_6.htm EX-99.1 16850
3 GRAPHIC gkc5xasf2e4c000001.jpg GRAPHIC 65192
  Complete submission text file 0001564590-21-043233.txt   274006

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fgen-20210811.xsd EX-101.SCH 5685
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20210811_lab.xml EX-101.LAB 18595
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20210811_pre.xml EX-101.PRE 11035
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20210811_htm.xml XML 3400
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 211162081
SIC: 2834 Pharmaceutical Preparations